Soliish, Inc.

What Soliish, Inc. does

Soliish, Inc. is a privately-held healthcare technology company that applies AI-powered facial biometrics to screen for obstructive sleep apnea (OSA) risk. The company's flagship product, FaceX, uses deep learning models trained on clinically validated datasets (including polysomnography data) to analyze craniofacial features from a selfie image captured via any standard web browser and produce an OSA risk score in under 60 seconds. The platform operates as a multi-tenant cloud SaaS offering, with no app download or specialized hardware required, and includes FlowX, a care pathway routing engine that connects at-risk patients to telehealth consultations, home sleep tests, and oral appliance evaluations. A separate PAP Replacement Automation product targets durable medical equipment (DME) providers managing CPAP replacement cycles.

The company serves five primary healthcare verticals: dental practices (chair-side screening during routine visits), primary care providers (intake-level screening), DME providers (upstream patient identification and replacement automation), employers (population-level sleep health programs for self-funded plans), and ENT practices (front-of-funnel patient engagement). The platform supports HL7/FHIR EHR integration via REST API, embedded SDK, iFrame, and Zapier, with white-label and co-branded deployment options available. Pricing is quote-based and not publicly disclosed, with revenue generated through enterprise SaaS subscriptions and managed services.

Soliish operates from Reston, Virginia (headquarters) and Cupertino, California (R&D), with five employees, and claims 100+ customer organizations, all within a US-only service territory. The company is HIPAA-compliant, GDPR-aligned for international partners, and CCPA-aware. Named customers and partners include Arima Health (strategic telehealth partner), Sleep Clinics of America, Dynamic Dental Sleep, Ohio Sleep Medicine Institute, Family Tree Dental, and the Oral Health Interoperability Alliance. No external funding rounds, revenue figures, or management team are publicly disclosed.

Name

Soliish, Inc.

Legal name

Soliish, Inc.

Website

https://soliish.com

Company type

Private

Founded year

2025

Operating status

Operating

Headcount range

1–10 employees

Short description

Soliish provides AI-powered facial biometric screening for obstructive sleep apnea risk via a web browser, serving dental practices, primary care, DME providers, employers, and ENT practices with SaaS screening and care pathway routing.

Ownership category

akta.pro rank

Product category

Sleep Apnea Screening Software

NAICS

Computer Systems Design and Related Services (54151)

SIC

Services-Health Services (8000), Services-Prepackaged Software (7372)

akta.pro industry

PRIMARYHLALAFAB

Respiratory & Sleep RPM (COPD, asthma, sleep apnea)

Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms

Keywords

• Sleep apnea screening
• AI facial biometrics
• Digital health platform
• Craniofacial risk analysis
• Telehealth care pathways

Headquarters

HQ city

Reston

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations

Revenue model

1. SaaS Platform Subscription: AI-powered sleep apnea screening platform delivered as a multi-tenant cloud-based online tool. Healthcare organizations pay for access to screening technology, analytics data, and care pathway management. Pricing appears quote-based for enterprise deployments.
2. White-Label/Branded Deployment: Flexible branding options from co-branded experiences to fully white-labeled deployments with custom domain and workflows for customer organizations.
3. PAP Device Replacement Automation: Automated workflow services for DME providers managing CPAP replacement cycles, including telehealth scheduling coordination and digital prescription packet delivery.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels4 records

Core offering

Soliish provides an AI-powered software platform that screens patients for obstructive sleep apnea (OSA) risk by analyzing craniofacial features from a selfie image, then routes at-risk patients to appropriate care pathways (telehealth consults, home sleep tests, oral appliance evaluations, or DME/PAP replacement). The platform combines FaceX (facial screening) and FlowX (care-pathway scheduling/routing) and is sold to healthcare organizations such as dental practices, primary care providers, DME providers, ENTs, health systems, and self-funded employers.

Product overview

Soliish offers a unified AI-powered health technology platform for sleep apnea screening and care pathway management. The core platform combines FaceX (AI selfie-based facial screening for OSA risk assessment) and FlowX (care-pathway routing and patient scheduling engine) into an integrated Digital Sleep Care Pathway. This connects patient engagement, telehealth specialist consultation, diagnostics, therapy-agnostic treatment options (CPAP, oral appliance, medication), and DME workflow integration. Additional offerings include PAP Replacement Automation for DMEs. The platform is accessible via web browser and mobile app stores (Apple App Store, Google Play Store), and supports HL7/FHIR EHR integration. The company serves multiple segments: dental practices, primary care, employers, ENTs, and DMEs.

Differentiator

Problem solved

Functional benefit

Brands

• FaceX: AI-powered facial screening tool that assesses sleep apnea risk from a selfie using craniofacial analysis.
• FlowX

Products and services

• Soliish Platform Multi-tenant cloud-based SaaS platform that collects facial data via smartphone/computer camera, uses AI-powered proprietary algorithms to analyze inputs and develop analytics for sleep apnea risk detection, and displays results for patient and healthcare provider review. Sold to healthcare organizations with quote-based subscription pricing.
• FaceX AI-powered facial screening tool that uses selfie-style face capture analyzed by deep-learning models trained on validated clinical datasets to assess craniofacial risk markers for obstructive sleep apnea (OSA). Runs in any standard web browser without app download and delivers a personalized sleep wellness summary in under 60 seconds.
• FlowX Care-pathway engine that handles scheduling and routing of patients to ENT diagnosis, treatment, and evaluation. Minimizes care leakage via structured routing and supports virtual specialist evaluation, home sleep testing, and ENT-led treatment pathways.
• PAP Replacement Automation Automated PAP device replacement cycle management for DME providers, including automated patient eligibility identification based on equipment age, warranty status, and insurance windows; smart outreach scheduling; telehealth visits with sleep providers; digital prescription packet delivery; and billing integration.
• Digital Sleep Care Pathway End-to-end digital pathway connecting patient engagement, sleep specialist consultation, diagnostics, therapy-agnostic prescription by a doctor, and therapy delivery. Includes user engagement, care navigation, instant access to licensed sleep specialists, integrated diagnostic testing pathways, and seamless workflow integration.

Quantifiable outcome

• 60% reduction in manual administrative workload across patient intake and screening workflows
• +4 more outcomes

Named customers5 records

Segments6 records

Ideal customer profiles6 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration8 records

AI capability6 records

Feature5 records

Partnerships

One partnership is on record.

• Arima HealthcoreStrategic or Co-development PartnerPartnership with Arima Health, described as a best-in-class national sleep telehealth care provider. Together they deliver end-to-end PAP device replacement automation for DMEs, combining Soliish's screening and workflow automation with Arima's sleep telehealth provider network for virtual evaluations, home sleep testing, and prescription management.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Oura: Consumer smart ring with sleep tracking, temperature, and respiratory features including overnight SpO2 trending. Broad incumbent in consumer sleep health that could expand upstream into OSA risk identification as a low-friction alternative to clinical screening.
• Inspire Medical Systems: Medical device company commercializing an implantable neurostimulation therapy for OSA, with established ENT and sleep specialist distribution. Broad incumbent operating downstream of Soliish's screening step but a potential channel partner for patient identification and care pathway completion.
• ResMed: Global leader in sleep apnea treatment devices (CPAP) and connected health (myAir, AirView). Broad incumbent in the OSA value chain with deep payer, DME, and provider relationships — represents both a potential channel partner and a competitive threat if it moves further upstream into screening.

Direct peers

• Wesper: Provider of disposable home sleep apnea tests with AI-assisted scoring and a digital care pathway. Direct peer in the digital-first OSA diagnosis and care-navigation category, though uses physiologic sensors rather than facial biometrics.
• Itamar Medical (ZOLL Itamar): Maker of WatchPAT, a home sleep apnea test device using peripheral arterial tone and other biometrics. Direct competitor in the OSA diagnostic pathway with FDA-cleared technology and established clinical evidence — operates upstream of Soliish's screening layer but addresses the same end market.
• Vivos Therapeutics: Provider of oral appliance therapy for OSA, with a dental-practice-focused distribution model and screening services. Direct peer in the dental sleep medicine segment where Soliish has its strongest current traction.
• EnsoData: AI-driven sleep diagnostics platform that applies machine learning to polysomnography and home sleep test data to automate scoring and identify sleep disorders. Closest direct peer to Soliish in the AI-for-sleep-diagnostics category, though EnsoData analyzes existing diagnostic data rather than facial biometrics.

Emerging players

• Withings: Connected health device company offering Sleep Analyzer with sleep apnea detection capability. Emerging player in consumer/clinical sleep monitoring with FDA-cleared features that overlap Soliish's screening use case, particularly in employer and direct-to-consumer channels.
• Acurable: Wearable device and platform for continuous respiratory monitoring including sleep apnea detection. Emerging player with partial overlap in AI-driven respiratory monitoring and home-based sleep diagnostics.
• Dreem (Beacon Biosignals): AI-powered sleep monitoring technology using wearable EEG and clinical-grade analytics for sleep staging and disorder detection. Emerging player intersecting with Soliish in AI-driven sleep health, with deeper physiological data capture but less primary-care/dental workflow integration.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/soliish

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Soliish, Inc.